Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
Experimental models of multiple sclerosis.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.
Asymptomatic subjects differ less from their twin siblings with MS than from healthy controls in cognitive functioning. A Finnish Twin Cohort study.
Health literacy and patient safety: help patients understand
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Neuromyelitis optica: not a multiple sclerosis variant.
Harry Lee Parker and paroxysmal dysarthria and ataxia.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.
Consent guidance: patients and doctors making decisions together
A Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
American Medical Association fact sheet on ocrelizumab
Dietary patterns not associated with the risk of multiple sclerosis
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
Rapidly progressive cerebellar ataxia in West Wales.
Multiple sclerosis and nutrition.
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought.
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial.
Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.

Pages